Let’s talk a bit about money:
Tumor Microenvironment Modulation Market to Hit USD 3.73 Billion by 2031 with a 7.4% CAGR - Key Trends and Insights
Quotes:
“To break immunotherapy resistance, it is critical to target treatments at the tumor microenvironment. Therapies that enhance T-cell activation and antigen presentation aim to prevent immune evasion. Combination therapies using TME modulation and immunotherapy are becoming a central part of oncological research.”
“The TME modulation market is poised for significant growth thanks to the increasing demand for advanced therapies and precision oncology strategies. Continuous innovations in molecular oncology, AI analytics, and biomarker-based treatment selection are revolutionizing the development of cancer treatments.”
Edit: That 3+ billion seems a bit low. Are there any economists in the group?